BACKGROUND: Insulin resistance was found in some but not in all previous studies of non-diabetic first degree relatives of Type 2 diabetic patients. Small study groups, ethnic differences and/or non-optimal techniques may explain the conflicting results. AIM: To study the impact of a family history of Type 2 diabetes on insulin action in a large group of non-diabetic Europeans using the 'gold standard' euglycaemic hyperinsulinaemic clamp technique. METHODS: Non-diabetic subjects (n = 235) with a positive family history of Type 2 diabetes (FH+) and 564 subjects with no family history of diabetes (FH-) were recruited from The European Group of Insulin Resistance (EGIR) database. This database includes measurements of insulin action using the insulin clamp technique (1 mU/kg per min) in normal glucose-tolerant individuals from 20 different European centres. In a subset of subjects the measurements were performed in combination with indirect calorimetry (n = 80 vs. 213 with and without family history of Type 2 diabetes). RESULTS: The body mass index (BMI) was slightly higher in FH+ compared with FH- (26.7 +/- 4.6 vs. 25.1 +/- 4.7 kg/m(2); P < 0.02). After correction for covariates according to differences between investigators and subject characteristics including BMI (multiple regression analysis), insulin-stimulated glucose disposal was lower in FH+ compared with FH- (P < 0.00001). Insulin-stimulated glucose oxidation was slightly increased in FH+ compared with FH-, and insulin-stimulated non-oxidative glucose metabolism was consequently markedly reduced in FH+ compared with FH- (P < 0.0005). CONCLUSION: Insulin resistance is present in European non-diabetic relatives of Type 2 diabetic patients. The insulin resistance is independent of degree of obesity and is restricted solely to the pathway of non-oxidative glucose metabolism. Diabet. Med. 18, 533-540 (2001)
BACKGROUND:Insulin resistance was found in some but not in all previous studies of non-diabetic first degree relatives of Type 2 diabeticpatients. Small study groups, ethnic differences and/or non-optimal techniques may explain the conflicting results. AIM: To study the impact of a family history of Type 2 diabetes on insulin action in a large group of non-diabetic Europeans using the 'gold standard' euglycaemic hyperinsulinaemic clamp technique. METHODS:Non-diabetic subjects (n = 235) with a positive family history of Type 2 diabetes (FH+) and 564 subjects with no family history of diabetes (FH-) were recruited from The European Group of Insulin Resistance (EGIR) database. This database includes measurements of insulin action using the insulin clamp technique (1 mU/kg per min) in normal glucose-tolerant individuals from 20 different European centres. In a subset of subjects the measurements were performed in combination with indirect calorimetry (n = 80 vs. 213 with and without family history of Type 2 diabetes). RESULTS: The body mass index (BMI) was slightly higher in FH+ compared with FH- (26.7 +/- 4.6 vs. 25.1 +/- 4.7 kg/m(2); P < 0.02). After correction for covariates according to differences between investigators and subject characteristics including BMI (multiple regression analysis), insulin-stimulated glucose disposal was lower in FH+ compared with FH- (P < 0.00001). Insulin-stimulated glucose oxidation was slightly increased in FH+ compared with FH-, and insulin-stimulated non-oxidative glucose metabolism was consequently markedly reduced in FH+ compared with FH- (P < 0.0005). CONCLUSION:Insulin resistance is present in European non-diabetic relatives of Type 2 diabeticpatients. The insulin resistance is independent of degree of obesity and is restricted solely to the pathway of non-oxidative glucose metabolism. Diabet. Med. 18, 533-540 (2001)
Authors: B Isomaa; B Forsén; K Lahti; N Holmström; J Wadén; O Matintupa; P Almgren; J G Eriksson; V Lyssenko; M-R Taskinen; T Tuomi; L C Groop Journal: Diabetologia Date: 2010-05-08 Impact factor: 10.122
Authors: James P DeLany; John J Dubé; Robert A Standley; Giovanna Distefano; Bret H Goodpaster; Maja Stefanovic-Racic; Paul M Coen; Frederico G S Toledo Journal: J Clin Endocrinol Metab Date: 2014-08-08 Impact factor: 5.958
Authors: S A Hills; B Balkau; S W Coppack; J M Dekker; A Mari; A Natali; M Walker; E Ferrannini Journal: Diabetologia Date: 2004-02-14 Impact factor: 10.122
Authors: Amy Darukhanavala; John N Booth; Lindsay Bromley; Harry Whitmore; Jacqueline Imperial; Plamen D Penev Journal: Diabetes Care Date: 2011-08-11 Impact factor: 19.112
Authors: C H T Tam; Y Wang; J Luan; H M Lee; A O Y Luk; G E Tutino; P C Y Tong; A P S Kong; W Y So; J C N Chan; R C W Ma Journal: Nutr Diabetes Date: 2014-03-10 Impact factor: 5.097